Australia markets closed

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2099-0.0131 (-5.87%)
At close: 04:00PM EDT
0.2200 +0.01 (+4.81%)
After hours: 07:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E 51.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.17
52-week change 3-90.81%
S&P500 52-week change 3-10.33%
52-week high 32.3100
52-week low 30.1310
50-day moving average 30.2488
200-day moving average 30.4351

Share statistics

Avg vol (3-month) 3307.48k
Avg vol (10-day) 3103.74k
Shares outstanding 527.98M
Implied shares outstanding 6N/A
Float 824.42M
% held by insiders 17.93%
% held by institutions 152.09%
Shares short (14 Mar 2023) 4198.66k
Short ratio (14 Mar 2023) 40.54
Short % of float (14 Mar 2023) 41.11%
Short % of shares outstanding (14 Mar 2023) 40.71%
Shares short (prior month 14 Feb 2023) 4208.15k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 317 Nov 2019
Ex-dividend date 4N/A
Last split factor 22:3
Last split date 314 Apr 2020

Financial highlights

Fiscal year

Fiscal year ends 29 June 2022
Most-recent quarter (mrq)30 Dec 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-29,656.45%

Management effectiveness

Return on assets (ttm)-88.68%
Return on equity (ttm)-190.07%

Income statement

Revenue (ttm)62k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-44.00%
Gross profit (ttm)64k
EBITDA -18.24M
Net income avi to common (ttm)-18.84M
Diluted EPS (ttm)-1.5900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)10.54M
Total cash per share (mrq)0.38
Total debt (mrq)685k
Total debt/equity (mrq)7.62
Current ratio (mrq)4.41
Book value per share (mrq)0.32

Cash flow statement

Operating cash flow (ttm)-18.16M
Levered free cash flow (ttm)-10.67M